Eluxadoline

BNF:
1.2
Status:
Red
Decision Date:
September 2017
 

Comments

RED1,2: As per NICE TA471 for treating irritable bowel syndrome with diarrhoea. Not to be used in patients who have undergone cholecystectomy or in those with biliary disorders due to risk of pancreatitis. MHRA December 2017.

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app